Tyrvaya

— THERAPEUTIC CATEGORIES —

Dry eye

PAGE CONTENTS

Jump to Section

Generic Name & Formulations

Indications

Dosage and Administration

Contraindications

Boxed Warnings

Warnings/Precautions

Pharmacokinetics

Interactions

Adverse Reactions

Clinical Trials

Note

Patient Counseling

Tyrvaya Generic Name & Formulations

Legal Class

General Description

Varenicline 0.03mg; per nasal spray; soln for intranasal use.

Pharmacological Class

Nicotinic acetylcholine receptor agonist.

How Supplied

Spray—2 (60 sprays/bottle)

Manufacturer

Oyster Point Pharma, Inc.

Generic Availability

Tyrvaya Indications

Indications

Dry eye disease.

Tyrvaya Dosage and Administration

Adult

Spray once in each nostril twice daily (approx. 12hrs apart).

Children

Not established.

Tyrvaya Contraindications

Not Applicable

Tyrvaya Boxed Warnings

Not Applicable

Tyrvaya Warnings/Precautions

Warnings/Precautions

Pregnancy. Nursing mothers.

Tyrvaya Pharmacokinetics

See Literature

Tyrvaya Interactions

Tyrvaya Adverse Reactions

Adverse Reactions

Sneezing, cough, throat irritation, instillation-site irritation.

Tyrvaya Clinical Trials

See Literature

Tyrvaya Note

Not Applicable

Tyrvaya Patient Counseling

See Literature